Our Technology – Cosaint Global LLC

What is MDO?

Molecularly Dissociated Oil (MDO) has special pharmacokinetic properties heretofore not realized with other oil-based formulations that have demonstrated enhanced bioavailability of CBDa. Primarily, this is a consequence of the fermentation process molecularly disassociating the added oil by lipases present in the bacteria, thereby generating a mixture of fatty acids, diglycerides and monoglycerides.

our technological capabilities

*Compared to average carrier oil

IMPROVED EFFICACY

Products containing MDO have significant improvements in overall efficacy, enhancing the body’s acceptance of active ingredients resulting in achieving its intended purpose more efficiently.

FASTER ONSET TIMES

Products containing MDO have significant improvements with overall speed and onset times: delivering the ingredient payload faster and safer than any other traditional carriers.

INCREASED POTENCY

Products containing MDO have significant improvements with overall active ingredient potency, protecting and preserving the power of ingredients within a highly bioavailable environment.

LONGER DURABILITY

Products containing MDO have significant improvements in overall durability providing noticeably longer results, active ingredients are delivered and released more efficiently and consistently.

PEAK BIOAVAILABILITY

Products containing MDO have significant improvements in overall bioavailability and absorption capabilities, evaporated amino acid nanoparticles penetrate lipid membranes and biofilms.

PROTECTED DELIVERY

Products containing MDO have significant improvements in overall ingredient protection, MDO encapsulation protects the ingredients while delivering them into the body which limits degradation.

MOLECULAR STABILITY

Products containing MDO have significant improvements in overall ingredient and molecular stability, even unstable ingredients such as raw CBDa is safe from decarboxylation when in a stable environment.

LIMITS SIDE-EFFECTS

Products containing MDO have significant improvements in overall limitations of adverse effects, reducing the amount of ingredients needed by up to 90% while still maintaining the same efficacy.

The Process

01. PRECISE FERMENTATION

Depending on the season, our formulas are fermented for 14–21 days in our custom-built bioreactors. This is where the bacteria break down the carbon molecule chains and lower the pH levels down from above 7 to around 4. When it reaches these pH levels, it’s achieved the proper state to put into our high-pressure evaporation chambers.

02. SURFACE EVAPORATION

From here, our fermented formula goes into our high-pressure evaporation chambers to remove certain contents of liquid generated by the fermentation process; this also exposes the molecular membrane, resulting in the outer layer of the molecules evaporating and allowing them to then dissociate; at this stage, we add an oxygen molecule.

03. Natural Fabrication

During the dissociation process our formulas’ molecular structures naturally nanosize, this is a result of removing the hardened outer membrane which causes the once larger molecular chained lipids to separate into their smaller and more bioavailable forms; at this stage, our Nanostructured Lipid Carriers (NLCs) are ready for oxygenating.

04. MOLECULAR OXYGENATION

Only once the molecular structure has dissociated can we initiate the final stage within our high-pressure evaporation chambers. From here, an oxygen molecule is infused to enhance the bioavailability and stability; after we achieve molecular oxygenation, the formula is ready to encapsulate active ingredients.

05. PROTECTED ENCAPSULATION

Our finished Molecularly Dissociated Oils (MDO) under the precise protocols will encapsulate most active ingredients. When heated up to a specific temperature, the added active ingredients are absorbed into the evaporated nanoparticles and once the formulation cools down, this completes the encapsulation and is ready for use.

The Result

Our (MDO) formulas have molecularly superior characteristics; they completely transform a selection of standard healthy ingredients into bio-enhanced game-changing drug delivery systems.

ENHANCED MOLECULAR CHARACTERISTICS

Our enhanced bio-formulations become antibacterial, antiviral, and antimicrobial by exposing and disassociating essential molecules. The exposed molecules can penetrate the outer lipid membrane of many viruses and bacteria, disabling them and preventing cell duplication, a task thought impossible by the medical community.

Increased Bioavailability

Encapsulating active ingredients within our dissociated Nanostructured Lipid Carriers (NLCs) delivers the payload into the bloodstream at far higher rates than traditional nanotechnology. Increased potency comes from enhancing bioavailability ensuring the maximum amount of active ingredients are absorbed and utilized by the body; shown to have upwards of 50x better delivery of ingredients over common carrier oils.

Faster Results

One of the most impressive qualities of our MDO is the dramatically decreased onset times of active ingredients, payloads absorb rapidly into the body delivering a much faster and longer-lasting experience. This nearly immediate reaction your body feels is the driving force behind the success our customers have when using our MDO formulas. No other natural product can do this.

The Outcome

A scientific breakthrough

This unique blend of lipids is combined with the active cannabinoids to produce micellar complexes that allow for enhanced transport of the cannabinoid payload through the lipophilic membranes. Once delivered in the body, the cannabinoids, most importantly CBDa, greatly suppress the enzymes associated with inflammation, which relates to the etiology of many disease states and conditions including cancer, COPD and pain. In very low amounts, CBDa can potentiate the activity of key receptors in the brain, like the serotonin receptor, which regulates mood, sleep, thermal regulation, appetite and more.